Mink Therapeutics
cells show tumor killing potential | Mink Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
October 2021
Slide
24 of 36
Related slides by other companies
SentiBio
SPAC
October 2021
senti discovered as a safety antigen that is highly expressed in healthy epithelial cells but not in tumor cells | SentiBio
Alkermes
Investor Day
March 2021
oncology goal activate innate and adaptive immune responses to drive tumor cell death enhanced antigen identification and presentation cell death chemotherapy radiation inhibitors targeted agents growth factor inhibitors immune system activation endogenous other immune cell mediated tumor cell death dendritic cell presenting antigen activated cells and cells activated cells attacking tumor tumor killing and release of antigens cells cells aes | Alkermes
RayzeBio
IPO
September 2023
extended imaging with shows tumor retention | RayzeBio
Immatics
Investor Presentation
November 2023
targeting mechanism of action | Immatics
Other recent decks by Mink Therapeutics
See all presentations (2 decks)
Investor Day
November 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io